View this API's:

Patents at Patent & Trademark Office Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Precose (acarbose) Tablets, Bayer NDA 20-482/S-011 10/29/02 11/18/02 Precose (acarbose) Tablets, Bayer NDA 20-482/S-010 8/16/99 5/19/00 Precose (acarbose) Tablets, Bayer Pharmaceutical Division NDA 20-482/S-007 and S-008 9/29/98 9/29/98 12/11/98 Precose Indications: S-007- provided for the new combination use of Precose for patients with type 2 diabetes treated with diet plus insulin; and S-008- provided for the new combination of Precose for patients with type 2 diabetes with diet and metformin.   For the latest approval information, locate this drug using this index.